Unlocking Drug Discovery with the World’s Largest iPSC Biobank

Time: 9:30 am
day: Conference Day One


  • Leveraging a unique resource of 2,000 patient-derived iPSC lines, to understand the links between genetics and drug response
  • This biobank empowers large-scale drug screening and paves the way for faster identification of effective and personalized therapies
  • By integrating automation and innovative technologies, we aim to unlock the full potential of iPSCs and revolutionize drug development